Arkolith/Insider Trading/JSPR/Form 4

Qiming U.S. Healthcare GP II, LLC

10% OwnerJasper Therapeutics, Inc. (JSPR) · full profile →Form 4 · filed Apr 11, 2023
Net Buying
Open-Market Buys
$4.0M
Open-Market Sells
$0
Net Open-Market Flow
$4.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 27, 2023Buy(P)2.7M$1.50$4.0M8.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-024058) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML